Login
$TSNDF
$0.69 +$0.04 (6.17%) Close

Company Executives

$TSNDF Management Team

Directors
5
serving now
Independent
Not stated
the proxy does not say
Average tenure
6.2 years
from year joined
CEO also chairs the board
No
Jason Wild
Director Age On board Independent Committees Other public boards 2025 pay Source
Craig Collard
60 2018
8 years
Not stated
Nominating and Corporate Governance Committee · Chair
None stated $223,288
Kara DioGuardi
55 2022
4 years
Not stated None stated None stated $209,921
Ira Duarte
57 2022
4 years
Not stated None stated None stated $223,288
Ed Schutter
74 2020
6 years
Not stated None stated Tidal Vision, Vitruvias Therapeutics, Inc., Establishment Labs Holdings Inc. $217,347
Jason Wild
53 2017
9 years
Not stated None stated Vitruvias Therapeutics, Inc., Tyson 2.0 Inc., Alumia, Inc. $754,749

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 16, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support